(R)-N-hydroxy-3-((S)-3-(4'-((R)-2-hydroxypropyl)-[1,1'-biphenyl]-4-yl)-2-oxooxazolidin-5-yl)-2-methyl-2-(methylsulfonyl)propanamide

ID: ALA4466622

Chembl Id: CHEMBL4466622

PubChem CID: 118059208

Max Phase: Preclinical

Molecular Formula: C23H28N2O7S

Molecular Weight: 476.55

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  C[C@@H](O)Cc1ccc(-c2ccc(N3C[C@H](C[C@](C)(C(=O)NO)S(C)(=O)=O)OC3=O)cc2)cc1

Standard InChI:  InChI=1S/C23H28N2O7S/c1-15(26)12-16-4-6-17(7-5-16)18-8-10-19(11-9-18)25-14-20(32-22(25)28)13-23(2,21(27)24-29)33(3,30)31/h4-11,15,20,26,29H,12-14H2,1-3H3,(H,24,27)/t15-,20+,23-/m1/s1

Standard InChI Key:  DDOYNQFIQRQZRM-ZNRXUEPQSA-N

Alternative Forms

1. Parent:

   

   ALA4466622

   (2R)-N-hydroxy-3-[(5S)-3-[4-[4-[(2R)-2-hydroxypropyl]phenyl]phenyl]-2-oxo-1,3-oxazolidin-5-yl]-2-methyl-2-methylsulfonylpropanamide

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 476.55

Molecular Weight (Monoisotopic): 476.1617

AlogP: 2.30

#Rotatable Bonds: 8

Polar Surface Area: 133.24

Molecular Species: NEUTRAL

HBA: 7

HBD: 3

#RO5 Violations: ┄

HBA (Lipinski): 9

HBD (Lipinski): 3

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 8.67

CX Basic pKa: ┄

CX LogP: 1.52

CX LogD: 1.50

Aromatic Rings: 2

Heavy Atoms: 33

QED Weighted: 0.39

Np Likeness Score: -0.29

References

1. Lee PS, Lapointe G, Madera AM, Simmons RL, Xu W, Yifru A, Tjandra M, Karur S, Rico A, Thompson K, Bojkovic J, Xie L, Uehara K, Liu A, Shu W, Bellamacina C, McKenney D, Morris L, Tonn GR, Osborne C, Benton BM, McDowell L, Fu J, Sweeney ZK..  (2018)  Application of Virtual Screening to the Identification of New LpxC Inhibitor Chemotypes, Oxazolidinone and Isoxazoline.,  61  (20): [PMID:30226381] [10.1021/acs.jmedchem.8b01287]

Source

Source(1):

• Scientific Literature